$DGX
Quest Diagnostics Inc Stock $dgx

$dgx Overview Financials Valuation SEC Filings Company Website

2017 Form 10-K Financial Statement

#000102207918000038 Filed on February 23, 2018

Income Statement

Concept	2017	2016 Q4	2016 Q3
Revenue	$7.402B	$1.861B	$1.885B
YoY Change	2.61%	0.65%	0.27%
Cost Of Revenue	$4.719B	$1.124B	$1.157B
YoY Change	2.23%	-2.01%	-0.43%
Gross Profit	$2.683B	$701.0M	$728.0M
YoY Change	-7.45%	0.29%	1.39%
Gross Profit Margin	36.25%	37.67%	38.62%
Selling, General & Admin	$1.443B	$67.00M	$409.0M
YoY Change	4.57%	-84.38%	1.74%
% of Gross Profit	53.78%	9.56%	56.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$270.0M	$63.00M	$63.00M
YoY Change	8.43%	-14.86%	-18.18%
% of Gross Profit	10.06%	8.99%	8.65%
Operating Expenses	$1.443B	$92.00M	$409.0M
YoY Change	4.57%	-80.0%	1.74%
Operating Profit	$1.165B	$609.0M	$322.0M
YoY Change	-8.77%	154.81%	-48.97%
Interest Expense	$153.0M	-$36.00M	$37.00M
YoY Change	6.25%	28.57%	5.71%
% of Operating Profit	13.13%	-5.91%	11.49%
Other Income/Expense, Net	-$135.0M	$2.000M	-$33.00M
YoY Change	-29.32%	-33.33%	-15.38%
Pretax Income	$1.000B	$242.0M	$289.0M
YoY Change	-9.09%	13.08%	-51.18%
Income Tax	$241.0M	$84.00M	$95.00M
% Of Pretax Income	24.1%	34.71%	32.87%
Net Earnings	$772.0M	$155.0M	$192.0M
YoY Change	19.69%	-17.55%	-43.86%
Net Earnings / Revenue	10.43%	8.33%	10.19%
Basic Earnings Per Share	$5.63	$1.11	$1.37
Diluted Earnings Per Share	$5.50	$1.09	$1.34
COMMON SHARES
Basic Shares Outstanding	137.0M shares	138.6M shares	139.0M shares
Diluted Shares Outstanding	140.0M shares		142.0M shares

Balance Sheet

Concept	2017	2016 Q4	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$137.0M	$359.0M	$406.0M
YoY Change	-61.84%	169.92%	230.08%
Cash & Equivalents	$137.0M	$359.0M	$406.0M
Short-Term Investments
Other Short-Term Assets	$150.0M	$164.0M	$188.0M
YoY Change	-8.54%	-57.18%	-64.19%
Inventory	$95.00M	$82.00M	$82.00M
Prepaid Expenses
Receivables	$924.0M	$926.0M	$966.0M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.306B	$1.531B	$1.642B
YoY Change	-14.7%	2.0%	-0.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.145B	$1.029B	$952.0M
YoY Change	11.27%	11.24%	7.45%
Goodwill		$6.000B	$6.000B
YoY Change		1.61%	1.78%
Intangibles		$949.0M	$972.0M
YoY Change		-3.56%	-3.19%
Long-Term Investments	$462.0M	$443.0M	$452.0M
YoY Change	4.29%	-6.34%	-5.44%
Other Assets	$136.0M	$148.0M	$155.0M
YoY Change	-8.11%	-14.94%	-4.91%
Total Long-Term Assets	$9.197B	$8.569B	$8.531B
YoY Change	7.33%	1.28%	1.25%
TOTAL ASSETS
Total Short-Term Assets	$1.306B	$1.531B	$1.642B
Total Long-Term Assets	$9.197B	$8.569B	$8.531B
Total Assets	$10.50B	$10.10B	$10.17B
YoY Change	3.99%	1.39%	0.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$224.0M	$261.0M	$1.039B
YoY Change	-14.18%	-6.45%	6.78%
Accrued Expenses	$649.0M	$254.0M
YoY Change	0.31%	-1.17%
Deferred Revenue
YoY Change
Short-Term Debt	$71.00M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$36.00M	$6.000M	$7.000M
YoY Change	500.0%	-96.23%	-95.63%
Total Short-Term Liabilities	$1.057B	$981.0M	$1.046B
YoY Change	7.75%	-16.37%	-7.68%
LONG-TERM LIABILITIES
Long-Term Debt	$3.748B	$3.728B	$3.815B
YoY Change	0.54%	6.76%	6.83%
Other Long-Term Liabilities	$663.0M	$654.0M	$542.0M
YoY Change	1.38%	27.24%	-20.29%
Total Long-Term Liabilities	$4.411B	$4.382B	$4.357B
YoY Change	0.66%	9.39%	2.49%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.057B	$981.0M	$1.046B
Total Long-Term Liabilities	$4.411B	$4.382B	$4.357B
Total Liabilities	$5.582B	$5.363B	$5.403B
YoY Change	2.01%	3.55%	0.35%
SHAREHOLDERS EQUITY
Retained Earnings		$6.613B	$6.520B
YoY Change		6.68%	7.48%
Common Stock		$2.547B	$2.528B
YoY Change		2.58%	2.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)		$4.460B	$4.324B
YoY Change		12.63%	10.39%
Treasury Stock Shares		79.00M shares	77.00M shares
Shareholders Equity	$4.921B	$4.628B	$4.663B
YoY Change
Total Liabilities & Shareholders Equity	$10.50B	$10.10B	$10.17B
YoY Change	3.99%	1.39%	0.98%

Cashflow Statement

Concept	2017	2016 Q4	2016 Q3
OPERATING ACTIVITIES
Net Income	$772.0M	$155.0M	$192.0M
YoY Change	19.69%	-17.55%	-43.86%
Depreciation, Depletion And Amortization	$270.0M	$63.00M	$63.00M
YoY Change	8.43%	-14.86%	-18.18%
Cash From Operating Activities	$1.175B	$351.0M	$301.0M
YoY Change	5.29%	29.04%	41.98%
INVESTING ACTIVITIES
Capital Expenditures	$252.0M	-$128.0M	-$61.00M
YoY Change	-13.99%	36.17%	17.31%
Acquisitions	$581.0M		$4.000M
YoY Change	317.99%		-88.57%
Other Investing Activities	-$1.000M	$46.00M	-$11.00M
YoY Change	-90.0%	-248.39%	-82.26%
Cash From Investing Activities	-$830.0M	-$82.00M	-$72.00M
YoY Change	553.54%	-34.4%	-36.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$465.0M
YoY Change	-21.19%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$592.0M	-291.0M	-106.0M
YoY Change	-19.78%	112.41%	-15.2%
NET CHANGE
Cash From Operating Activities	$1.175B	351.0M	301.0M
Cash From Investing Activities	-$830.0M	-82.00M	-72.00M
Cash From Financing Activities	-$592.0M	-291.0M	-106.0M
Net Change In Cash	-$247.0M	-22.00M	123.0M
YoY Change	-198.41%	-320.0%	-555.56%
FREE CASH FLOW
Cash From Operating Activities	$1.175B	$351.0M	$301.0M
Capital Expenditures	$252.0M	-$128.0M	-$61.00M
Free Cash Flow	$923.0M	$479.0M	$362.0M
YoY Change	12.15%	30.87%	37.12%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0001022079
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	135637852	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	15100000000	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	QUEST DIAGNOSTICS INC
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2016Q3	dgx	Agreementto Outsource Billingand Collection Function AgreementtoOutsourceBillingandCollectionFunction	P10Y
CY2015	dgx	Cash Paid For Business Acquisitions CashPaidForBusinessAcquisitions	67000000	USD
CY2016	dgx	Cash Paid For Business Acquisitions CashPaidForBusinessAcquisitions	139000000	USD
CY2017	dgx	Cash Paid For Business Acquisitions CashPaidForBusinessAcquisitions	593000000	USD
CY2017Q4	dgx	Debt Instrument Fair Value Basis Adjustment Attributable To Hedged Debt DebtInstrumentFairValueBasisAdjustmentAttributableToHedgedDebt	33000000	USD
CY2016Q4	dgx	Deferred Tax Liability Investments Investmentsin Subsidiariesand Equitymethodinvestments DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments	87000000	USD
CY2017Q4	dgx	Deferred Tax Liability Investments Investmentsin Subsidiariesand Equitymethodinvestments DeferredTaxLiabilityInvestmentsInvestmentsinSubsidiariesandEquitymethodinvestments	79000000	USD
CY2015	dgx	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rateand Repatriationof Foreign Earnings Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateandRepatriationofForeignEarningsPercent	0.000
CY2016	dgx	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rateand Repatriationof Foreign Earnings Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateandRepatriationofForeignEarningsPercent	0.000
CY2017	dgx	Effective Income Tax Rate Reconciliation Changein Enacted Tax Rateand Repatriationof Foreign Earnings Percent EffectiveIncomeTaxRateReconciliationChangeinEnactedTaxRateandRepatriationofForeignEarningsPercent	-0.104
CY2015	dgx	Fair Value Of Net Assets Acquired FairValueOfNetAssetsAcquired	63000000	USD
CY2016	dgx	Fair Value Of Net Assets Acquired FairValueOfNetAssetsAcquired	139000000	USD
CY2017	dgx	Fair Value Of Net Assets Acquired FairValueOfNetAssetsAcquired	599000000	USD
CY2017Q4	dgx	Finite Lived Intangible Assets Estimated Amortization Expense Total FiniteLivedIntangibleAssetsEstimatedAmortizationExpenseTotal	883000000	USD
CY2016Q4	dgx	Investments Excluding Equity Method Investments InvestmentsExcludingEquityMethodInvestments	60000000	USD
CY2017Q4	dgx	Investments Excluding Equity Method Investments InvestmentsExcludingEquityMethodInvestments	69000000	USD
CY2016Q4	dgx	Liabilities Not Currently Deductible Non Current Dta LiabilitiesNotCurrentlyDeductibleNonCurrentDta	189000000	USD
CY2017Q4	dgx	Liabilities Not Currently Deductible Non Current Dta LiabilitiesNotCurrentlyDeductibleNonCurrentDta	129000000	USD
CY2017Q4	dgx	Long Term Debt Maturities Gross LongTermDebtMaturitiesGross	3848000000	USD
CY2016Q4	dgx	Merger Consideration Payable Current MergerConsiderationPayableCurrent	2000000	USD
CY2017Q4	dgx	Merger Consideration Payable Current MergerConsiderationPayableCurrent	7000000	USD
CY2015	dgx	Mergerconsiderationpaidpayablenet Mergerconsiderationpaidpayablenet	4000000	USD
CY2016	dgx	Mergerconsiderationpaidpayablenet Mergerconsiderationpaidpayablenet	0	USD
CY2017	dgx	Mergerconsiderationpaidpayablenet Mergerconsiderationpaidpayablenet	-6000000	USD
CY2015	dgx	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Redeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest	751000000	USD
CY2016	dgx	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Redeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest	689000000	USD
CY2017	dgx	Net Income Loss Including Portion Attributableto Noncontrolling Interest Excluding Redeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributabletoNoncontrollingInterestExcludingRedeemableNoncontrollingInterest	817000000	USD
CY2016Q4	dgx	Net Operating Loss Carryfowards Net Of Valuation Allowance NetOperatingLossCarryfowardsNetOfValuationAllowance	120000000	USD
CY2017Q4	dgx	Net Operating Loss Carryfowards Net Of Valuation Allowance NetOperatingLossCarryfowardsNetOfValuationAllowance	83000000	USD
CY2016Q4	dgx	Noncurrent Deferred Tax Assets Liabilities Net NoncurrentDeferredTaxAssetsLiabilitiesNet	-159000000	USD
CY2017Q4	dgx	Noncurrent Deferred Tax Assets Liabilities Net NoncurrentDeferredTaxAssetsLiabilitiesNet	-166000000	USD
CY2015	dgx	Paymentofdeferredbusinessacquisitionconsideration Paymentofdeferredbusinessacquisitionconsideration	51000000	USD
CY2016	dgx	Paymentofdeferredbusinessacquisitionconsideration Paymentofdeferredbusinessacquisitionconsideration	0	USD
CY2017	dgx	Paymentofdeferredbusinessacquisitionconsideration Paymentofdeferredbusinessacquisitionconsideration	3000000	USD
CY2016	dgx	Paymentsof Debt Retirement Costs PaymentsofDebtRetirementCosts	47000000	USD
CY2016Q4	dgx	Percentage Of Accounts Receivable Due From Government Payers PercentageOfAccountsReceivableDueFromGovernmentPayers	0.15
CY2017Q4	dgx	Percentage Of Accounts Receivable Due From Government Payers PercentageOfAccountsReceivableDueFromGovernmentPayers	0.14
CY2015	dgx	Percentageof Net Revenuesfrom Diagnostic Information Services Business PercentageofNetRevenuesfromDiagnosticInformationServicesBusiness	0.9000
CY2016	dgx	Percentageof Net Revenuesfrom Diagnostic Information Services Business PercentageofNetRevenuesfromDiagnosticInformationServicesBusiness	0.9000
CY2017	dgx	Percentageof Net Revenuesfrom Diagnostic Information Services Business PercentageofNetRevenuesfromDiagnosticInformationServicesBusiness	0.90
CY2016Q4	dgx	Percentageof Receivables Due From Patients PercentageofReceivablesDueFromPatients	0.17
CY2017Q4	dgx	Percentageof Receivables Due From Patients PercentageofReceivablesDueFromPatients	0.20
CY2017Q4	dgx	Purchase Price Discount Espp PurchasePriceDiscountEspp	0.15
CY2015	dgx	Reductions For Changes In Judgment ReductionsForChangesInJudgment	11000000	USD
CY2016	dgx	Reductions For Changes In Judgment ReductionsForChangesInJudgment	1000000	USD
CY2017	dgx	Reductions For Changes In Judgment ReductionsForChangesInJudgment	2000000	USD
CY2017	dgx	Remaining Terms Of Lease Obligations Maximum RemainingTermsOfLeaseObligationsMaximum	P30Y
CY2016Q1	dgx	Restructuring Integration Charges RestructuringIntegrationCharges	21000000	USD
CY2016Q2	dgx	Restructuring Integration Charges RestructuringIntegrationCharges	19000000	USD
CY2016Q3	dgx	Restructuring Integration Charges RestructuringIntegrationCharges	18000000	USD
CY2016Q4	dgx	Restructuring Integration Charges RestructuringIntegrationCharges	24000000	USD
CY2017Q1	dgx	Restructuring Integration Charges RestructuringIntegrationCharges	18000000	USD
CY2017Q2	dgx	Restructuring Integration Charges RestructuringIntegrationCharges	23000000	USD
CY2017Q3	dgx	Restructuring Integration Charges RestructuringIntegrationCharges	23000000	USD
CY2017Q4	dgx	Restructuring Integration Charges RestructuringIntegrationCharges	42000000	USD
CY2015	dgx	Revenues Generated By Medicaid And Medicare Programs RevenuesGeneratedByMedicaidAndMedicarePrograms	0.17
CY2016	dgx	Revenues Generated By Medicaid And Medicare Programs RevenuesGeneratedByMedicaidAndMedicarePrograms	0.17
CY2017	dgx	Revenues Generated By Medicaid And Medicare Programs RevenuesGeneratedByMedicaidAndMedicarePrograms	0.16
CY2016Q1	dgx	Sharebasedcompensationexcesstaxbenefitamount Sharebasedcompensationexcesstaxbenefitamount	2000000	USD
CY2016Q2	dgx	Sharebasedcompensationexcesstaxbenefitamount Sharebasedcompensationexcesstaxbenefitamount	2000000	USD
CY2016Q3	dgx	Sharebasedcompensationexcesstaxbenefitamount Sharebasedcompensationexcesstaxbenefitamount	3000000	USD
CY2016Q4	dgx	Sharebasedcompensationexcesstaxbenefitamount Sharebasedcompensationexcesstaxbenefitamount	2000000	USD
CY2016	dgx	Sharebasedcompensationexcesstaxbenefitamount Sharebasedcompensationexcesstaxbenefitamount	9000000	USD
CY2017Q1	dgx	Sharebasedcompensationexcesstaxbenefitamount Sharebasedcompensationexcesstaxbenefitamount	16000000	USD
CY2017Q2	dgx	Sharebasedcompensationexcesstaxbenefitamount Sharebasedcompensationexcesstaxbenefitamount	13000000	USD
CY2017Q3	dgx	Sharebasedcompensationexcesstaxbenefitamount Sharebasedcompensationexcesstaxbenefitamount	7000000	USD
CY2017Q4	dgx	Sharebasedcompensationexcesstaxbenefitamount Sharebasedcompensationexcesstaxbenefitamount	1000000	USD
CY2017	dgx	Sharebasedcompensationexcesstaxbenefitamount Sharebasedcompensationexcesstaxbenefitamount	37000000	USD
CY2015	dgx	Sharestocoveremployeepayrolltaxwithholdingsonstockbenefitplansvalue Sharestocoveremployeepayrolltaxwithholdingsonstockbenefitplansvalue	7000000	USD
CY2016	dgx	Sharestocoveremployeepayrolltaxwithholdingsonstockbenefitplansvalue Sharestocoveremployeepayrolltaxwithholdingsonstockbenefitplansvalue	10000000	USD
CY2017	dgx	Sharestocoveremployeepayrolltaxwithholdingsonstockbenefitplansvalue Sharestocoveremployeepayrolltaxwithholdingsonstockbenefitplansvalue	23000000	USD
CY2015	dgx	Temporary Equity Adjustment To Redemption Value TemporaryEquityAdjustmentToRedemptionValue	14000000	USD
CY2017	dgx	Temporaryequity Noncontrollinginterest Decreasefrom Distributionsto Noncontrolling Interest Holders TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders	4000000	USD
CY2015	dgx	Termination Of Interest Rate Swap Agreements TerminationOfInterestRateSwapAgreements	0	USD
CY2016	dgx	Termination Of Interest Rate Swap Agreements TerminationOfInterestRateSwapAgreements	54000000	USD
CY2017	dgx	Termination Of Interest Rate Swap Agreements TerminationOfInterestRateSwapAgreements	0	USD
CY2017Q4	dgx	Unrecorded Unconditional Purchase Obligation Duewithin Twoand Three Years UnrecordedUnconditionalPurchaseObligationDuewithinTwoandThreeYears	21000000	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	975000000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1021000000	USD
CY2016Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	231000000	USD
CY2017Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	224000000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	926000000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	924000000	USD
CY2016Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	62000000	USD
CY2017Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	82000000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3000000	USD
CY2017Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	9000000	USD
CY2016Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	31000000	USD
CY2017Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	32000000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	254000000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	246000000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2400000000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2526000000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-72000000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-48000000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2545000000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2612000000	USD
CY2015	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	5000000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52000000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	69000000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	79000000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	265000000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	269000000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	81000000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	72000000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	74000000	USD
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1000000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2000000	shares
CY2016Q4	us-gaap	Assets Assets	10100000000	USD
CY2017Q4	us-gaap	Assets Assets	10503000000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	1531000000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	1306000000	USD
CY2016Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	9000000	USD
CY2017Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	3000000	USD
CY2017Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	2000000	USD
CY2016Q4	us-gaap	Bank Overdrafts BankOverdrafts	30000000	USD
CY2017Q4	us-gaap	Bank Overdrafts BankOverdrafts	71000000	USD
CY2015Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	32000000	USD
CY2016Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	95000000	USD
CY2017Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	273000000	USD
CY2017	us-gaap	Business Acquisition Revenue Reported By Acquired Entity For Last Annual Period BusinessAcquisitionRevenueReportedByAcquiredEntityForLastAnnualPeriod	75000000	USD
CY2015	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	63000000	USD
CY2016	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	139000000	USD
CY2017	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	587000000	USD
CY2015Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	26000000	USD
CY2016Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	44000000	USD
CY2017Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	242000000	USD
CY2015	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	15000000	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	9000000	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	26000000	USD
CY2015	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	3000000	USD
CY2016	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2017	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	7000000	USD
CY2016	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2017	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	12000000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	192000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	133000000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	359000000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	137000000	USD
CY2015	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-59000000	USD
CY2016	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	226000000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-222000000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.38
CY2015Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.38
CY2015Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.38
CY2015Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.38
CY2015	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.52
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2016Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2016Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2016Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.45
CY2016	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.65
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.45
CY2017Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.45
CY2017Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.45
CY2017Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.45
CY2017	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	1.80
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2006Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2006Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2006Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	216000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	216000000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	2000000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	2000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	698000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	611000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	796000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	44000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	51000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	52000000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	742000000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	662000000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	848000000	USD
CY2016Q4	us-gaap	Cost Method Investments CostMethodInvestments	6000000	USD
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	9000000	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	4657000000	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	4616000000	USD
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	4719000000	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	6094000000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	6238000000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	6544000000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	231000000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	346000000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	226000000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	3000000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1000000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1000000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	27000000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	45000000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	5000000	USD
CY2016Q4	us-gaap	Debt Current DebtCurrent	6000000	USD
CY2017Q4	us-gaap	Debt Current DebtCurrent	36000000	USD
CY2016Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	3900000000	USD
CY2017Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	4000000000	USD
CY2017Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	11000000	USD
CY2015	us-gaap	Decrease In Restricted Cash DecreaseInRestrictedCash	0	USD
CY2016	us-gaap	Decrease In Restricted Cash DecreaseInRestrictedCash	0	USD
CY2017	us-gaap	Decrease In Restricted Cash DecreaseInRestrictedCash	25000000	USD
CY2017Q4	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	35000000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	104000000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	33000000	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-20000000	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	1000000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	2000000	USD
CY2017Q4	us-gaap	Deferred Gain Loss On Discontinuation Of Fair Value Hedge DeferredGainLossOnDiscontinuationOfFairValueHedge	56000000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	112000000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	37000000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9000000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	7000000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	4000000	USD
CY2017	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	27000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	32000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	4000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	222000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	204000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	155000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	58000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	41000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	94000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	63000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54000000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	56000000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	57000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	191000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	170000000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	533000000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	403000000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	77000000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	76000000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	76000000	USD
CY2017	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.05
CY2015	us-gaap	Depreciation Depreciation	223000000	USD
CY2016	us-gaap	Depreciation Depreciation	177000000	USD
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.016
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.018
CY2017	us-gaap	Depreciation Depreciation	196000000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	304000000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	249000000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	270000000	USD
CY2015	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	219000000	USD
CY2016	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	231000000	USD
CY2017	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	247000000	USD
CY2016Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	62000000	USD
CY2017Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	61000000	USD
CY2015Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	55000000	USD
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	62000000	USD
CY2017Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	61000000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.92
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.72
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.38
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.37
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.11
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	4.58
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.19
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.40
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.18
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.86
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5.63
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.87
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.71
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.37
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.34
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.09
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	4.51
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.16
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.37
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.15
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.82
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5.50
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.338
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.395
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.234
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.008
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Deductions Other EffectiveIncomeTaxRateReconciliationDeductionsOther	0.036
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.007
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.010
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0.011
CY2017Q1	us-gaap	Gross Profit GrossProfit	734000000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	773000000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	741000000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	742000000	USD
CY2017	us-gaap	Gross Profit GrossProfit	2990000000	USD
CY2016	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	7000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1100000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1100000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1000000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	11000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	4000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-7000000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1103000000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1086000000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1030000000	USD
CY2015	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	23000000	USD
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Minority Interest Income Expense EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense	-0.019
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.015
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.027
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.033
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.001
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.002
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.008
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.020
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.026
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.033
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.038
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	316000000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	325000000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	20000000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	32000000	USD
CY2017	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	67000000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	443000000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	462000000	USD
CY2015	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	63000000	USD
CY2016	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	139000000	USD
CY2017	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	657000000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	460000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	534000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	493000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	82000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	72000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	74000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	81000000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	81000000	USD
CY2015	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	334000000	USD
CY2016	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	118000000	USD
CY2017	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2015Q4	us-gaap	Goodwill Goodwill	5905000000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	6000000000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	6335000000	USD
CY2015	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	33000000	USD
CY2016	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	95000000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	335000000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	719000000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	751000000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	728000000	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	701000000	USD
CY2016	us-gaap	Gross Profit GrossProfit	2899000000	USD
CY2016	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	39000000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	35000000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	373000000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	429000000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	241000000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	319000000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	361000000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	243000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-24000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	56000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-8000000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	262000000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	343000000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	298000000	USD
CY2015	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-41000000	USD
CY2016	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	42000000	USD
CY2017	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	16000000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	42000000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-25000000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	26000000	USD
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2000000	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3000000	shares
CY2016Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1409000000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1653000000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	949000000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1119000000	USD
CY2015	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1000000	USD
CY2016	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1000000	USD
CY2017	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	2000000	USD
CY2015	us-gaap	Interest Expense InterestExpense	154000000	USD
CY2016	us-gaap	Interest Expense InterestExpense	144000000	USD
CY2017	us-gaap	Interest Expense InterestExpense	153000000	USD
CY2015	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-153000000	USD
CY2016	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-143000000	USD
CY2017	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-151000000	USD
CY2015	us-gaap	Interest Paid InterestPaid	172000000	USD
CY2016	us-gaap	Interest Paid InterestPaid	148000000	USD
CY2017	us-gaap	Interest Paid InterestPaid	159000000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	46000000	USD
CY2017Q4	us-gaap	Interest Payable Current InterestPayableCurrent	46000000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	82000000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	95000000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	224000000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	216000000	USD
CY2017	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	219000000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10100000000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10503000000	USD
CY2016	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2017	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	58000000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	981000000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1057000000	USD
CY2016Q4	us-gaap	Litigation Reserve LitigationReserve	5000000	USD
CY2017Q4	us-gaap	Litigation Reserve LitigationReserve	2000000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	3734000000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	3784000000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3728000000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3748000000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6000000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	36000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	2153000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	36000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	552000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	803000000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	304000000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3728000000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3748000000	USD
CY2016Q4	us-gaap	Malpractice Loss Contingency Accrual Undiscounted MalpracticeLossContingencyAccrualUndiscounted	117000000	USD
CY2017Q4	us-gaap	Malpractice Loss Contingency Accrual Undiscounted MalpracticeLossContingencyAccrualUndiscounted	118000000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	32000000	USD
CY2017Q4	us-gaap	Minority Interest MinorityInterest	34000000	USD
CY2015	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	42000000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	41000000	USD
CY2017	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	47000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-518000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-691000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-592000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-362000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-152000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-805000000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	821000000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1069000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1175000000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	709000000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	103000000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	195000000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	192000000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	155000000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	645000000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	164000000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	193000000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	161000000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	254000000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	772000000	USD
CY2015	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	44000000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	12000000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	14000000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	13000000	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	12000000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	51000000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	11000000	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	14000000	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	14000000	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	13000000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	52000000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	706000000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	642000000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	769000000	USD
CY2015	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	11000000	USD
CY2017	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	4000000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-296000000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-191000000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-135000000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	1399000000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	1277000000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	1165000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	659000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	177000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	48000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	69000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	99000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	139000000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	127000000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	148000000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	136000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	3000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	2000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	1000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-15000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-34000000	USD
CY2016	us-gaap	Repayments Of Debt RepaymentsOfDebt	1724000000	USD
CY2017	us-gaap	Repayments Of Debt RepaymentsOfDebt	182000000	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	11000000	USD
CY2017	us-gaap	Restructuring Charges RestructuringCharges	30000000	USD
CY2015Q4	us-gaap	Restructuring Reserve RestructuringReserve	19000000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	9000000	USD
CY2017Q4	us-gaap	Restructuring Reserve RestructuringReserve	22000000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6613000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	20000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-11000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-34000000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	24000000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-1000000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2017	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	0	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	654000000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	663000000	USD
CY2015	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6000000	USD
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	6000000	USD
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	6000000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-143000000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-48000000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000000	USD
CY2015	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-11000000	USD
CY2016	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	13000000	USD
CY2017	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1000000	USD
CY2015	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	3000000	USD
CY2016	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	3000000	USD
CY2017	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	3000000	USD
CY2015	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1000000	USD
CY2016	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-10000000	USD
CY2017	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-2000000	USD
CY2015	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	224000000	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	590000000	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	465000000	USD
CY2016	us-gaap	Payments For Restructuring PaymentsForRestructuring	21000000	USD
CY2017	us-gaap	Payments For Restructuring PaymentsForRestructuring	17000000	USD
CY2015	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	212000000	USD
CY2016	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	223000000	USD
CY2017	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	247000000	USD
CY2015	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	42000000	USD
CY2016	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	41000000	USD
CY2017	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	51000000	USD
CY2015	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7000000	USD
CY2016	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	10000000	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	23000000	USD
CY2015	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	67000000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	139000000	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	581000000	USD
CY2015	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	33000000	USD
CY2016	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2017	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	263000000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	293000000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	252000000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1.00
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	155000000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	150000000	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	14000000	USD
CY2017Q4	us-gaap	Prepaid Taxes PrepaidTaxes	37000000	USD
CY2015	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2016	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	270000000	USD
CY2017	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	1000000	USD
CY2015	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	2453000000	USD
CY2016	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1869000000	USD
CY2017	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	205000000	USD
CY2015	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	63000000	USD
CY2016	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2017	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	4000000	USD
CY2015	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-21000000	USD
CY2016	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-45000000	USD
CY2017	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	40000000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	60000000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	73000000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	130000000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	753000000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	115000000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	209000000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	205000000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	167000000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	696000000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	175000000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	207000000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	175000000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	267000000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	824000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3429000000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3671000000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1029000000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1145000000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	297000000	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	308000000	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	315000000	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	77000000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	80000000	USD
CY2015	us-gaap	Repayments Of Debt RepaymentsOfDebt	2537000000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7138000000	USD
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	7493000000	USD
CY2016Q1	us-gaap	Sales Revenue Net SalesRevenueNet	1863000000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	1906000000	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	1885000000	USD
CY2016Q4	us-gaap	Sales Revenue Net SalesRevenueNet	1861000000	USD
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	7515000000	USD
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	1899000000	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	1943000000	USD
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	1931000000	USD
CY2017Q4	us-gaap	Sales Revenue Net SalesRevenueNet	1936000000	USD
CY2017	us-gaap	Sales Revenue Net SalesRevenueNet	7709000000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1679000000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1681000000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1750000000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	52000000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	69000000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	79000000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.021
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.024
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.019
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.21
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.216
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.198
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.017
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.014
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.021
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.57
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.35
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.98
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y3M18D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y3M18D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y2M12D
CY2015	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	1000000	shares
CY2016	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	2000000	shares
CY2017	us-gaap	Stock Issued During Period Shares Treasury Stock Reissued StockIssuedDuringPeriodSharesTreasuryStockReissued	2000000	shares
CY2015	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	21000000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22000000	USD
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	23000000	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	60000000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	73000000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	130000000	USD
CY2017Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	917000000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	4628000000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	4921000000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4330000000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4713000000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4660000000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4955000000	USD
CY2015	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	14000000	USD
CY2014Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	USD
CY2015Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	70000000	USD
CY2016Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	77000000	USD
CY2017Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	80000000	USD
CY2015	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	2000000	USD
CY2016	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	7000000	USD
CY2017	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	7000000	USD
CY2015	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	54000000	USD
CY2016Q4	us-gaap	Trading Securities Equity TradingSecuritiesEquity	51000000	USD
CY2017Q4	us-gaap	Trading Securities Equity TradingSecuritiesEquity	58000000	USD
CY2015	us-gaap	Trading Securities Realized Gain Loss TradingSecuritiesRealizedGainLoss	0	USD
CY2016	us-gaap	Trading Securities Realized Gain Loss TradingSecuritiesRealizedGainLoss	3000000	USD
CY2017	us-gaap	Trading Securities Realized Gain Loss TradingSecuritiesRealizedGainLoss	8000000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	79000000	shares
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	81000000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4460000000	USD
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	4783000000	USD
CY2015	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	224000000	USD
CY2016	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	590000000	USD
CY2017	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	465000000	USD
CY2016Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	24000000	USD
CY2017Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	20000000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	122000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	91000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	98000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	115000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	27000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	3000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	5000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	5000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	12000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	23000000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	12000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	13000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	2000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	1000000	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	3000000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	7000000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	6000000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	64000000	USD
CY2017Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	53000000	USD
CY2017Q4	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	99000000	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145000000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	142000000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140000000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	144000000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	140000000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	137000000	shares
CY2017	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">    </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;"></font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Background</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.  The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services. The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers and accountable care organizations ("ACOs"). The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals. The Company is the world's leading provider of diagnostic information services. The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry and hundreds of M.D.s and Ph.D.s, many of whom are recognized leaders in their fields. The Company's Diagnostic Solutions ("DS") businesses offer a variety of solutions for life insurers and healthcare organizations and clinicians. The Company is the leading provider of risk assessment services for the life insurance industry. In addition, the Company offers healthcare organizations and clinicians robust information technology solutions. Prior to the sale of the Focus Diagnostics products business on May 13, 2016 (see Note 6), the Company's diagnostics products business manufactured and marketed diagnostic products. Prior to the contribution of its clinical trials testing business to the Q</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">2</sup></font><font style="font-family:inherit;font-size:10pt;"> Solutions joint venture on July 1, 2015 (see Note 6), the Company's clinical trials testing business was a leading provider of central laboratory testing for clinical trials.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001022079-18-000038-index-headers.html	Edgar Link	pending
0001022079-18-000038-index.html	Edgar Link	pending
0001022079-18-000038.txt	Edgar Link	pending
0001022079-18-000038-xbrl.zip	Edgar Link	pending
clinicaltestingindustry.jpg	Edgar Link	pending
dgx-20171231.xml	Edgar Link	completed
dgx-20171231.xsd	Edgar Link	pending
dgx-20171231_cal.xml	Edgar Link	unprocessable
dgx-20171231_def.xml	Edgar Link	unprocessable
dgx-20171231_lab.xml	Edgar Link	unprocessable
dgx-20171231_pre.xml	Edgar Link	unprocessable
dgx123117ex104.htm	Edgar Link	pending
dgx123117ex109.htm	Edgar Link	pending
dgx1231201710-k.htm	Edgar Link	pending
dgx12312017ex211.htm	Edgar Link	pending
dgx12312017ex231.htm	Edgar Link	pending
dgx12312017ex311.htm	Edgar Link	pending
dgx12312017ex312.htm	Edgar Link	pending
dgx12312017ex321.htm	Edgar Link	pending
dgx12312017ex322.htm	Edgar Link	pending
dgx1231201_chart-18627a02.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
table16netrevenuesa04.jpg	Edgar Link	pending
table23.jpg	Edgar Link	pending
table2strategya03.jpg	Edgar Link	pending
visiongoalsvaluesa02.jpg	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DGX
Quest Diagnostics Inc Stock $dgx

2017 Form 10-K Financial Statement

#000102207918000038 Filed on February 23, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DGX Quest Diagnostics Inc Stock $dgx

2017 Form 10-K Financial Statement

#000102207918000038 Filed on February 23, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DGX
Quest Diagnostics Inc Stock $dgx